Patient Name : Mohamed Atique Shaikh Age / Gender : 35 years / Male Bill ID : 192059 Patient ID : 154126 Source : SELF Aadhaar No : 459694969774 Referral : Dr. Mahesh Kadam Collection Time : Jan 28, 2022, 09 :42 p.m. Receiving Time : Jan 29, 2022, 11 :42 a.m. Reporting Time : Jan 29, 2022, 01 :07 a.m. Sample ID : MB2901220132 COVID - 19 Rapid Antigen Test Aim: To screen the patient samples for presence of SARS - CoV - 2 antigen. Sample type: Nasopharyngeal swab Results: Target Results SARS - CoV2 Negative Note : • Negative results of symptomatic individuals should be confirmed by COVID RT - PCR test. • The kits used are approved by ICMR. Test methodology: GenBody COVID - 19 Ag is a immunochromatographic assay kit for qualitative detection of SARS - CoV - 2 antigen in Nasophar yngeal and Oropharyngeal swabs. Antigens of SARS - CoV - 2 in the specimen react with the anti - SARS - CoV - 2 monoclonal antibody - coupled gold conjugate followed by reaction with anti - SARS - CoV - 2 monoclonal antibodies immobilized in the test line. When the sample contains SARS - CoV - 2 antigens, a visible line appears in the test region on the membrane. The solution continues to migrate to encounter a control reagent that binds a control conjugate, thereby producing another band i n the control region. GenBody COVID - 19 Ag is also very useful do directly detect SARS - CoV - 2 antigens from human swab samples. Clinical significance: Coronavirus disease - 2019 (COVID - 19) is an infectious disease caused by a newly discovered coronavirus, Severe acute respiratory syndrome coronavi rus - 2 (SARS - CoV - 2). Most people infected with the COVID - 19 virus experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes , chronic respiratory disease, and cancer are more likely to develop serious illness. Disclaimers: 1. It is assumed that the sample received in the laboratory, belongs to the same patient as mentioned in the TRF. 2. We would like to state that the report(s) generated from the tests do not provide any diagnosis or opinion, neither do they recommend any cure in any manner. The laboratory hereby recommends that the patients should take assistance of the prescribing clinician or the certified physician/doctor to interpret the report(s) generated. 3. The test results should be carefully correlated considering the present clinical condition of the patient and other relevant findings if any related to the patient. Patient Name : Mohamed Atique Shaikh Age / Gender : 35 years / Male Bill ID : 192059 Patient ID : 154126 Source : SELF Aadhaar No : 459694969774 Referral : Dr. Mahesh Kadam Collection Time : Jan 28, 2022, 09 :42 p.m. Receiving Time : Jan 29, 2022, 11 :42 a.m. Reporting Time : Jan 29, 2022, 01 :07 a.m. Sample ID : MB2901220132 4. This report cannot be used for any medico - legal purpose. 5. A detected result does not distinguish between a viable/ replicating organism and a non - viable organism. 6. Conflicting results may arise due to inappropriate specimen and contamination during specimen collection. 7. Sensitivity of the test would be influenced by the quality of the sample submitted and the stage of the infection. 8. A negative result does not rule out the possibility of an infecti on. References: 1. Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China. Information for Healthcare Professionals. https://www.cdc.gov/coronavirus/2019 - nCoV /hcp/index.html. 2. World Health Organization. Novel Coronavirus (2019 - nCoV) technical guidance. https://www.who.int/emergencies/diseases/novel - coronavirus - 20 19/technical - guidance. **END OF REPORT**